Medicure’s Only Risk
Medicure (TSXV: MPH)'s only risk is that FDA Priority Review Vouchers decline in value. Last…
Articles
Articles
Medicure’s Long-Term Market Cap Chart
The last time Medicure (TSXV: MPH) launched FDA Phase 3 trials in November 2006, its…
Articles
SAGA Gains 6.67% to $0.40 with Multiple Big Catalysts Ahead
Saga Metals (TSXV: SAGA) is continuing to break out big, rising by 6.67% on Friday…
Articles
Total Metals Gains Third Straight Day on Strong Volume
Total Metals (TSXV: TT) gained by 2.13% on Friday to $0.24 per share on strong…
Articles
Ueno Bank Collapses, President of Paraguay Resigns
Yes, Ueno Bank did sponsor our Latino Wall Street Hispanic Prosperity Gala at Mar-a-Lago in…
Articles
Total Metals Gold Grades at High Lake Among Highest in Canada
Total Metals (TSXV: TT) gained by 2.17% yesterday to $0.235 per share after gaining by…
Articles
Medicure Will Be #1 Largest Gainer of 2027
Medicure (TSXV: MPH) or MCUJF on the U.S. OTC was originally founded in September 1997 as…
Articles
Important NIA Gold Update
Gold is reacting very favorably to the Democrats sweeping last night up $120 to $4,050…
Articles
Is Medicure the Next GW Pharmaceuticals?
The FDA 100% wants there to be an FDA approved pharmaceutical-grade version of pyridoxal-5'-phosphate (PLP)…
Articles
How to Capitalize on TrumpRx and Cost Plus Drugs
TrumpRx and Cost Plus Drugs Are Reshaping How Americans Buy Prescriptions. Here Is a Publicly…